Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Study of the use of Pregabalin

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: FERNANDEZ, Leonardo (Colegio de Farmacéuticos de Buenos Aires Lomas de Zamora, filial Lomas de Zamora, Lomas de Zamora, Argentina)
  • Co-author(s): Leonardo jorge Fernandez:|Veronica Gregorio:|Marcela De Caria:|Karina Perrotta:|Rita Metz:
  • Abstract:

    Pregabalin is anantiepileptic drug with structural analogue of GABA. Its therapeutic indications approved by FDA,only in adults are: combined treatment of partial seizures , treatment of neuropathic pain, treatment of generalized anxiety disorder(GAD)and fibromyalgia. The latter use is not approved by the EMA

    By a cross-sectional study conducted

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses